Mission
SEE SCHEDULE O
Public Charity
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Based in PHILADELPHIA, PA, THE CHILDREN'S HOSPITAL OF PHILADELPHIA operates as a Public Charity. The organization reported $4.2B in revenue, $3.8B in expenses, $9.1B in total assets for fiscal year 2025. Imperigo tracks 1,063 reported grant relationships connected to this organization totaling approximately $1.4B.
EIN: 231352166
PHILADELPHIA, PA
Specialty Hospitals
NTEE: E24
Latest filing: 2025
Total Revenue$4.2B
Total Expenses$3.8B
Total Assets$9.1B
Grant Records1,063
Funding Total$1.4B
Filing Years2021–2025
Sample Grants Received
PEDIATRIC CANCER RESEARCH
$2,317,893
RESEARCH
$845,000
MUSIC THERAPY PROGRAM
$600,000
DR. MATTHEW HOCKING FOR PEDIATRIC CANCER RESEARCH
$250,000
1. In conjunction with Tel Aviv University and Institut de Génétique Moléculaire de Montpellier - Transformational Science Grant: Molecular Characterization of the Therapeutic Effect of Exogenous Nav1.1 - $150,000. 2. In conjunction with MIT and Harvard University - Research Grant: Base Editing for the Treatment and Prevention of Dravet Syndrome - $90,000. Details for each of these projects can be found at https://dravetfoundation.org/dsf-funded-research/
$240,000
Showing up to 5 of 1,063 total records — full history available with membership.
Officers & Directors
TRUSTEE
Brian M Mcneill
EVP & CHIEF HR OFFICER
Calvin Allen
CHAIR & TRUSTEE
Christopher Gheysens
TRUSTEE
Damien Dwin
TRUSTEE
David G Nichols Md
TRUSTEE
Diem H Nguyen Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $4.2B | $3.8B | $9.1B |
| 2024 | $3.9B | $3.6B | $8.1B |
| 2023 | $3.4B | $3.3B | $7.4B |
| 2022 | $3.2B | $2.9B | $7.0B |
| 2021 | $2.9B | $2.6B | $6.5B |
Between 2021 and 2025, reported annual revenue grew from $2.9B to $4.2B (+45%), with total assets most recently reported at $9.1B.
Interactive year-over-year charts and full filing details available with membership.